LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $450,000 | -26.4% | 6,190 | +5.6% | 0.04% | +28.6% |
| Q4 2019 | $611,000 | +11.7% | 5,860 | +6.6% | 0.04% | +34.6% |
| Q3 2019 | $547,000 | -48.6% | 5,495 | -41.1% | 0.03% | -44.7% |
| Q2 2019 | $1,065,000 | -70.4% | 9,330 | -67.4% | 0.05% | -66.2% |
| Q1 2019 | $3,597,000 | +3.4% | 28,615 | +11.6% | 0.14% | -0.7% |
| Q4 2018 | $3,480,000 | -47.2% | 25,645 | +6.8% | 0.14% | -27.8% |
| Q3 2018 | $6,593,000 | +91.7% | 24,020 | +44.7% | 0.19% | +84.8% |
| Q2 2018 | $3,439,000 | +35.1% | 16,600 | +7.7% | 0.10% | +29.6% |
| Q1 2018 | $2,545,000 | – | 15,410 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |